|
Medingo - a 50% Elron company
(directly and indirectly through RDC)
Insulin micro-pump for people with diabetes
Medingo develops technologies for the welfare of people living with diabetes. Medingo's flagship product, Solo™, is a miniature, lightweight insulin patch pump which uses no tubing, is detachable, discreet and simple to use. The patch can be placed under clothing or any part of the body without interfering with the patient's daily activites, and can be programmed according to the patient's personal insulin needs. With its pay-as-you-go model and no high upfront cost, Solo will improve access to insulin pumps for more people.
|
